3-(1-(4-Chlorobenzyl)-5-fluoro-3-methylindol-2-yl)-2,2-dimethylpropanoic acid (BioDeep_00000895123)
代谢物信息卡片
化学式: C21H21ClFNO2 (373.1244768)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC1=C(N(C2=C1C=C(C=C2)F)CC3=CC=C(C=C3)Cl)CC(C)(C)C(=O)O
InChI: InChI=1S/C21H21ClFNO2/c1-13-17-10-16(23)8-9-18(17)24(12-14-4-6-15(22)7-5-14)19(13)11-21(2,3)20(25)26/h4-10H,11-12H2,1-3H3,(H,25,26)
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- M Tardif, Y Bergeron, D Beauchamp, M G Bergeron. Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy.
Antimicrobial agents and chemotherapy.
1993 Dec; 37(12):2727-32. doi:
10.1128/aac.37.12.2727. [PMID: 8109943] - M Bunke, L Wilder, A Martin. Protection of glomerular filtration rate by the thromboxane receptor antagonist L655,240 during low dose cyclosporine administration.
Prostaglandins.
1992 Apr; 43(4):351-60. doi:
10.1016/0090-6980(92)90035-r. [PMID: 1535164] - K C Malcolm, F A Fitzpatrick. Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways.
The Journal of pharmacology and experimental therapeutics.
1992 Mar; 260(3):1244-9. doi:
". [PMID: 1532033] - M Cirino, H Morton, C MacDonald, J Hadden, A W Ford-Hutchinson. Thromboxane A2 and prostaglandin endoperoxide analogue effects on porcine renal blood flow.
The American journal of physiology.
1990 Jan; 258(1 Pt 2):F109-14. doi:
10.1152/ajprenal.1990.258.1.f109. [PMID: 2301587] - R L Hébert, P Sirois, G E Plante. Inhibition of platelet-activating factor induced renal hemodynamic and tubular dysfunctions with L-655,240, a new thromboxane-prostaglandin endoperoxide antagonist.
Canadian journal of physiology and pharmacology.
1989 Apr; 67(4):304-8. doi:
10.1139/y89-049. [PMID: 2758373] - M G Sirois, S Jancar, P Braquet, G E Plante, P Sirois. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240.
Prostaglandins.
1988 Nov; 36(5):631-44. doi:
10.1016/0090-6980(88)90009-3. [PMID: 3238010] - M A Levitt, G Stahl, A M Lefer. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
Resuscitation.
1988 Jul; 16(3):211-20. doi:
10.1016/0300-9572(88)90047-0. [PMID: 2845544] - R A Hall, J Gillard, Y Guindon, G Letts, E Champion, D Ethier, J Evans, A W Ford-Hutchinson, R Fortin, T R Jones. Pharmacology of L-655,240 (3-[1-(4-chlorobenzyl)-5-fluoro-3-methyl-indol-2-yl]2,2-dimethylpro pan oic acid); a potent, selective thromboxane/prostaglandin endoperoxide antagonist.
European journal of pharmacology.
1987 Mar; 135(2):193-201. doi:
10.1016/0014-2999(87)90611-x. [PMID: 3582493]